Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.
SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
The interdisciplinary team of lung cancer researcher Michelle Mendoza and biomedical engineer Jeffrey Weiss have received a multimillion dollar grant to study the origin of malignant tumors in the ...
Researchers at City of Hope have found that cell mutations are necessary but not always sufficient for tumors to form.
The widespread utilization of chest CT scans has increased the importance of the proper evaluation of incidentally found lung nodules. The primary goal in the evaluation of these nodules is to ...
Lung cancer isn’t just about smoking cigarettes! A poor diet can affect lung health and increase cancer risk. So, eat right ...
Lung cancer remains one of the most widespread and deadliest malignant tumors globally, with a particularly high mortality rate among all cancers. Recently, immunotherapy, particularly immune ...